SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000078003-21-000118
Filing Date
2021-12-15
Accepted
2021-12-15 16:18:14
Documents
13
Period of Report
2021-12-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 PFIZER 8-K DECEMBER 9, 2021 pfe-20211209.htm   iXBRL 8-K 42717
  Complete submission text file 0000078003-21-000118.txt   228097

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20211209.xsd EX-101.SCH 2948
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20211209_def.xml EX-101.DEF 15885
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20211209_lab.xml EX-101.LAB 31638
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20211209_pre.xml EX-101.PRE 16557
6 EXTRACTED XBRL INSTANCE DOCUMENT pfe-20211209_htm.xml XML 15388
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 211494405
SIC: 2834 Pharmaceutical Preparations